ICU Medical ROE 2006-2020 | ICUI

Current and historical return on equity (ROE) values for ICU Medical (ICUI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. ICU Medical ROE for the three months ending March 31, 2020 was 10.45%.
ICU Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.09B $1.38B 6.51%
2019-12-31 $0.10B $1.38B 7.67%
2019-09-30 $0.07B $1.34B 5.69%
2019-06-30 $0.05B $1.32B 3.67%
2019-03-31 $0.06B $1.28B 4.34%
2018-12-31 $0.03B $1.26B 2.31%
2018-09-30 $0.09B $1.26B 6.96%
2018-06-30 $0.09B $1.26B 7.13%
2018-03-31 $0.02B $1.23B 1.53%
2017-12-31 $0.07B $1.20B 6.00%
2017-09-30 $0.03B $1.14B 2.85%
2017-06-30 $0.05B $1.12B 5.38%
2017-03-31 $0.10B $1.14B 13.31%
2016-12-31 $0.06B $0.66B 10.16%
2016-09-30 $0.06B $0.65B 9.67%
2016-06-30 $0.06B $0.62B 9.50%
2016-03-31 $0.05B $0.60B 9.29%
2015-12-31 $0.05B $0.58B 8.17%
2015-09-30 $0.05B $0.57B 8.82%
2015-06-30 $0.04B $0.54B 7.20%
2015-03-31 $0.03B $0.52B 5.79%
2014-12-31 $0.03B $0.51B 5.31%
2014-09-30 $0.03B $0.49B 6.68%
2014-06-30 $0.04B $0.49B 7.97%
2014-03-31 $0.04B $0.47B 8.51%
2013-12-31 $0.04B $0.47B 9.32%
2013-09-30 $0.04B $0.43B 9.50%
2013-06-30 $0.04B $0.42B 10.11%
2013-03-31 $0.04B $0.40B 11.06%
2012-12-31 $0.04B $0.39B 11.26%
2012-09-30 $0.05B $0.37B 13.56%
2012-06-30 $0.04B $0.35B 13.33%
2012-03-31 $0.04B $0.34B 13.80%
2011-12-31 $0.04B $0.32B 14.38%
2011-09-30 $0.04B $0.31B 11.91%
2011-06-30 $0.04B $0.31B 12.39%
2011-03-31 $0.03B $0.29B 12.73%
2010-12-31 $0.03B $0.27B 11.72%
2010-09-30 $0.03B $0.26B 10.62%
2010-06-30 $0.02B $0.25B 9.30%
2010-03-31 $0.02B $0.25B 8.34%
2009-12-31 $0.03B $0.27B 9.34%
2009-09-30 $0.03B $0.28B 10.58%
2009-06-30 $0.03B $0.27B 11.74%
2009-03-31 $0.03B $0.26B 11.78%
2008-12-31 $0.03B $0.25B 10.59%
2008-09-30 $0.02B $0.24B 9.72%
2008-06-30 $0.02B $0.23B 8.58%
2008-03-31 $0.02B $0.22B 7.67%
2007-12-31 $0.02B $0.21B 10.74%
2007-09-30 $0.03B $0.22B 11.05%
2007-06-30 $0.03B $0.23B 11.53%
2007-03-31 $0.03B $0.23B 13.17%
2006-12-31 $0.03B $0.23B 11.74%
2006-09-30 $0.02B $0.22B 11.27%
2006-06-30 $0.02B $0.21B 11.87%
2006-03-31 $0.02B $0.20B 11.96%
2005-12-31 $0.02B $0.19B 11.43%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.702B $1.266B
ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 24.99
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.39
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.736B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.673B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 179.15
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
OraSure Technologies (OSUR) United States $0.872B 0.00
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.599B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
InfuSystems Holdings (INFU) United States $0.278B 154.11
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Fonar (FONR) United States $0.166B 14.75
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00